Clinical practice guidelines for the diagnosis and surveillance of BAP1 tumour predisposition syndrome

BRCA1-associated protein-1 (BAP1) is a recognised tumour suppressor gene. Germline BAP1 pathogenic/likely pathogenic variants are associated with predisposition to multiple tumours, including uveal melanoma, malignant pleural and peritoneal mesothelioma, renal cell carcinoma and specific non-malignant neoplasms of the skin, as part of the autosomal dominant BAP1-tumour predisposition syndrome. The overall lifetime risk for BAP1 carriers to develop at least one BAP1-associated tumour is up to 85%, although due to ascertainment bias, current estimates of risk are likely to be overestimated. As for many rare cancer predisposition syndromes, there is limited scientific evidence to support the utility of surveillance and, therefore, management recommendations for BAP1 carriers are based on expert opinion. To date, European recommendations for BAP1 carriers have not been published but are necessary due to the emerging phenotype of this recently described syndrome and increased identification of BAP1 carriers via large gene panels or tumour sequencing. To address this, the Clinical Guideline Working Group of the CanGene-CanVar project in the United Kingdom invited European collaborators to collaborate to develop guidelines to harmonize surveillance programmes within Europe. Recommendations with respect to BAP1 testing and surveillance were achieved following literature review and Delphi survey completed by a core group and an extended expert group of 34 European specialists including Geneticists, Ophthalmologists, Oncologists, Dermatologists and Pathologists. It is recognised that these largely evidence-based but pragmatic recommendations will evolve over time as further data from research collaborations informs the phenotypic spectrum and surveillance outcomes.</p

Sexually transmitted proctitis

Proctitis caused by sexually transmitted agents is usually taken for inflammatory bowel diseases, because of similar complaints, such as pain, bleeding and mucopurulent discharge, as well as the histopathology. Thus, its treatment is postponed and, sometimes, complications appear. The most common etiologic agents are Neisseria gonorrhoeae, Chlamydia trachomatis, Treponema pallidum and Herpes simplex. In order to avoid dissemination and complications, laboratory tests are essential for diagnosis and proper therapy. The objective of this article was to raise awareness to sexually transmitted diseases in proctitis etiology, as well as their diagnosis and treatment.<br>As retites provocadas por agentes sexualmente transmissíveis são frequentemente confundidas com doenças inflamatórias intestinais, uma vez que as queixas mais comuns, que incluem dor, sangramento e secreção mucopurulenta, e o padrão histopatológico são semelhantes. Dessa maneira, o tratamento é postergado e, algumas vezes, as complicações aparecem. Os agentes mais comuns incluem a Neisseria gonorrhoeae, a Chlamydia trachomatis, o Treponema pallidum e o Herpes simplex. Exames laboratoriais sensíveis e específicos para confirmação diagnóstica são essenciais para o tratamento correto, evitando a disseminação e as sequelas. O objetivo deste artigo foi chamar a atenção para as doenças sexualmente transmissíveis na etiologia das retites, bem como seu diagnóstico e tratamento